The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer.
Year: 2009
Type: article
Source: PubMed
Institutions: National Cancer Institute, Center for Cancer Research
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W69111101